Prognostic factors in soft tissue sarcomas: The Aarhus experience

Author： Vraa S. Keller J. Nielsen O.S. Sneppen O. Jurik A.G. Jensen O.M.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.12, 1998-11, pp. : 1876-1882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perioperative Interstitial Brachytherapy for Soft Tissue Sarcomas: Prognostic Factors and Long-Term Results of 155 Patients

By Laskar Siddhartha Bahl Gaurav Puri Ajay Agarwal Manish Muckaden MaryAnn Patil Nikhilesh Jambhekar Nirmala Gupta Sudeep Deshpande Deepak Shrivastava Shyam Dinshaw Ketayun

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 560-567

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of CD155 mRNA expression in soft tissue sarcomas

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1771-1776

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Significance of Dicer Cellular Levels in Soft Tissue Sarcomas

By Papachristou Dionysios J. Rao Uma N. M. Korpetinou Angeliki Giannopoulou Efstathia Sklirou Emilia Kontogeorgakos Vasileios Kalofonos Haralabos P.

Cancer Investigation, Vol. 30, Iss. 2, 2012-02 ,pp. : 172-179

Informa Healthcare

Access to resources Recommend Favorite

Soft Tissue Sarcomas

By Womer R.B.

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2230-2234

Elsevier

Access to resources Recommend Favorite

Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group

By Nielsen Ole S. Mouridsen Henning Daugaard Soren Verweij Jaap Dombernowsky Per Van Glabbeke Martine Kirkpatrick Anne

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 31-35

Informa Healthcare

Access to resources Recommend Favorite